Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease

被引:0
|
作者
Jeong Woo Kim
Young-Sun Lee
Yang Shin Park
Baek-Hui Kim
Soo Yeon Lee
Jong Eun Yeon
Chang Hee Lee
机构
[1] Korea University Guro Hospital,Department of Radiology
[2] Korea University College of Medicine,Department of Radiology
[3] Korean Armed Forces Capital Hospital,Department of Internal Medicine
[4] Korea University Guro Hospital,Department of Pathology
[5] Korea University College of Medicine,undefined
[6] Korea University Guro Hospital,undefined
[7] Korea University College of Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Non-alcoholic steatohepatitis (NASH) is a complex disease consisting of various components including steatosis, lobular inflammation, and ballooning degeneration, with or without fibrosis. Therefore, it is difficult to diagnose NASH with only one imaging modality. This study was aimed to evaluate the feasibility of magnetic resonance imaging (MRI) for predicting NASH and to develop a non-invasive multiparametric MR index for the detection of NASH in non-alcoholic fatty liver disease (NAFLD) patients. This prospective study included 47 NAFLD patients who were scheduled to undergo or underwent ultrasound-guided liver biopsy within 2 months. Biopsy specimens were graded as NASH or non-NASH. All patients underwent non-enhanced MRI including MR spectroscopy (MRS), MR elastography (MRE), and T1 mapping. Diagnostic performances of MRS, MRE, and T1 mapping for grading steatosis, activity, and fibrosis were evaluated. A multiparametric MR index combining fat fraction (FF), liver stiffness (LS) value, and T1 relaxation time was developed using linear regression analysis. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance of the newly devised MR index. Twenty NASH patients and 27 non-NASH patients were included. Using MRS, MRE, and T1 mapping, the mean areas under the curve (AUCs) for grading steatosis, fibrosis, and activity were 0.870, 0.951, and 0.664, respectively. The multiparametric MR index was determined as 0.037 × FF (%) + 1.4 × LS value (kPa) + 0.004 × T1 relaxation time (msec) −3.819. ROC curve analysis of the MR index revealed an AUC of 0.883. The cut-off value of 6 had a sensitivity of 80.0% and specificity of 85.2%. The multiparametric MR index combining FF, LS value, and T1 relaxation time showed high diagnostic performance for detecting NASH in NAFLD patients.
引用
收藏
相关论文
共 50 条
  • [21] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
    Bugianesi, E
    Marzocchi, R
    Villanova, N
    Marchesini, G
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
  • [22] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Jürgen Kurt Rockstroh
    [J]. Current HIV/AIDS Reports, 2017, 14 : 47 - 53
  • [23] An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Marin, Veronica
    Rosso, Natalia
    Dal Ben, Matteo
    Raseni, Alan
    Boschelle, Manuela
    Degrassi, Cristina
    Nemeckova, Ivana
    Nachtigal, Petr
    Avellini, Claudio
    Tiribelli, Claudio
    Gazzin, Silvia
    [J]. PLOS ONE, 2016, 11 (07):
  • [24] Predictors of non-alcoholic steatohepatitis and fibrosis in non-alcoholic fatty liver disease.
    Pong, JP
    Elariny, H
    Younoszai, A
    [J]. HEPATOLOGY, 2002, 36 (04) : 407A - 407A
  • [25] THE ROLE OF BLOOD GROUPS IN NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS
    Karagoz, Hatice
    Erden, Abdulsamet
    Ozer, Ozerhan
    Cetinkaya, Ali
    Avci, Deniz
    Gencer, Vedat
    Arik, Ferhat
    Kalan, Ugur
    Gorkem, Hasan
    Karaman, Hatice
    Karaman, Ahmet
    [J]. ACTA MEDICA MEDITERRANEA, 2017, 33 (02): : 205 - 210
  • [26] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children
    Kodhelaj, K.
    Resuli, B.
    Petrela, E.
    Malaj, V.
    Jaze, H.
    [J]. MINERVA PEDIATRICA, 2014, 66 (01) : 23 - 30
  • [27] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Hattori, Sachiko
    Nomoto, Kazuomi
    Suzuki, Tomohiko
    Hayashi, Seishu
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [28] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Sachiko Hattori
    Kazuomi Nomoto
    Tomohiko Suzuki
    Seishu Hayashi
    [J]. Diabetology & Metabolic Syndrome, 13
  • [29] Fatty Liver and Non-Alcoholic Steatohepatitis
    Saito, Takafumi
    Misawa, Keiko
    Kawata, Sumio
    [J]. INTERNAL MEDICINE, 2007, 46 (02) : 101 - 103
  • [30] Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges
    Hashimoto, Etsuko
    Tokushige, Katsutoshi
    Ludwig, Jurgen
    [J]. HEPATOLOGY RESEARCH, 2015, 45 (01) : 20 - 28